Transfusion-associated Babesiosis in a 7-month-old Infant after Bidirectional Glenn Procedure

Congenital Heart Disease

Volumn 5, Issue 6, 2010, Pages 607-613

  Nicholson, George T ^a   Walsh, Christine A ^a   Madan, Rebecca P ^b  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Babesiosis; Congenital Heart Disease; Transfusion

Indexed keywords

ATOVAQUONE; AZITHROMYCIN;

ARTICLE; BABESIOSIS; BLOOD CULTURE; BLOOD SMEAR; BLOOD TRANSFUSION; CASE REPORT; DOSE RESPONSE; DRUG RESPONSE; FEVER; GLENN SHUNT; HUMAN; INFANT; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; TRICUSPID VALVE ATRESIA; URINALYSIS;

ANTI-INFECTIVE AGENTS; ATOVAQUONE; AZITHROMYCIN; BABESIA MICROTI; BABESIOSIS; DRUG THERAPY, COMBINATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEVER; FONTAN PROCEDURE; HUMANS; INFANT; MALE; TREATMENT OUTCOME;

EID: 78649647043     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2010.00384.x     Document Type: Article

References (42)

1. Dobroszycki J, Herwaldt BL, Boctor F, et al. A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA. 1999;281:927-930.
2. Herwaldt BL, Neitzel DF, Gorlin JB, et al. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion. 2002;42:1154-1158.
3. Lux JZ, Weiss D, Linden JV, et al. Transfusion-associated babesiosis after heart transplant. Emerg Infect Dis. 2003;9:116-119.
4. CDC. Evaluation of rapid influenza diagnostic tests for detection of novel influenza (H1N1) Virus-United States, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:826-829.
5. McQuiston JH, Childs JE, Chamberland ME, Tabor E. Transmission of tick-borne agents by blood transfusion: a review of known and potential risks in the United States. Transfusion. 2000;40:274-284.
6. Quick RE, Herwaldt BL, Thromford JW, et al. Babesiosis in Washington State: a new species of Babesia? Ann Intern Med. 1993;119:284-290.
7. Persing DH, Herwaldt BL, Glaser C, et al. Infection with a Babesia-like organism in northern California. N Engl J Med. 1995;332:298-303.
8. Herwaldt BL, Persing DH, Precigout EA, et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med. 1996;124:643-650.
9. Meldrum SC, Birkhead GS, White DJ, et al. Human babesiosis in New York State: an epidemiologic description of 136 cases. Clin Infect Dis. 1992;15:1019-1023.
10. Fox LM, Wingerter S, Ahmed A, et al. Neonatal babesiosis: case report and review of the literature. Pediatr Infect Dis J. 2006;25:169-173.
11. Qureshi MH, Garvy BA, Pomeroy C, et al. A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression. J Virus Res. 2005;114(1-2):35-44.
12. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol. 2001;2:1077-1084.
13. Pomeroy C, Filice GA, Hitt JA, Jordan MC. Cytomegalovirus-induced reactivation of Toxoplasma gondii pneumonia in mice: lung lymphocyte phenotypes and suppressor function. J Infect Dis. 1992;166(3):677-681.
14. Wang X, Messerle M, Sapinoro R, et al. Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol. 2003;77(13):7182-7192.
15. Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and Azithromycin for the treatment of Babesiosis. N Engl J Med. 2000;343:1454-1458.
16. Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM. Atovaquone in the treatment of Babesia microti infections in hamsters. Am J Trop Med Hyg. 1996;55:219-222.
17. Dorman SE, Cannon ME, Telford SR, Frank KM, Churchill WH. Fulminant babesiosis treated with clindamycin, quinine, and whole-blood exchange transfusion. Transfusion. 2000;40:375-380.
18. Cable RG, Leiby DA. Risk and prevemntion of transfusion-transmitted babesiosis and other tick-borne diseases. Curr Opin Hematol. 2003;10:405-411.
19. Matsui T, Inoue R, Kajimoto K, et al. First documentation of transfusion-associated babesiosis in Japan. Rinsho Ketsueki. 2000;41:628-634.
20. Jassoum BS, Fong IW, Hannach B, et al. Transfusion-transmitted babesiosis in Ontario: first reported case in Canada. Can Commun Dis Rep. 2000;26:9-13.
21. Krause PJ, Spielman A, Telford S, et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 1998;339:160-165.
22. Cable RG, Trouern-trend J. Tick-borne infections. In: Linden JV, Bianco C, eds. Blood Safety and Surveillance. New York: Marcel Dekker; 2001:399-422.
23. Hunfeld KP, Hildbrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol. 2008;38:1219-1237.
24. Fine A, Slavinski S. 2009 DOHMH Advisory #24: Tick-borne Disease Advisory, June 23, 2009.
25. Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang. 2006;90:157-165.
26. Leiby DA, Gill JE. Transfusion-transmitted tick-borne unfections: a cornucopia of threats. Tranfusion Medicine Reviews. 2004;18:293-306.
27. Mattia AR, Waldron MA, Sierra LS. Use of the quantitative buffy coat system for detection of parasitemia in patients with babesiosis. J Clin Microbiol. 1993;31:2816-2818.
28. Eberhard ML, Walker EM, Steurer FJ. Survival and infectivity of Babesia in blood maintained at 25 C and 2-4 C. J Parasitol. 1995;81:790-792.
29. Popovsky MA, Lindberg LE, Syrek AL, et al. Prevalence of Babesia antibody in a selected blood donor population. Transfusion. 1998;28:59-61.
30. Linden JV, Wong SJ, Chu FK, et al. Transfusion-associated transmission of babesiosis in new York State. Transfusion. 2000;40:285-289.
31. Leiby DA, Chung APS, Cable RG, et al. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophilia in blood donors. Transfusion. 2002;42:1585-1591.
32. Fritz CL, Kjemtrup AM, Conrad PA, et al. Seroepidemiology of emerging tick-borne infectious diseases in a Northern California community. J Infect Dis. 1997;175:1432-1439.
33. Homer MJ, Aguilar-Delfin I, Telford SR, et al. Babesiosis. Clin Microbiol Rev. 2000;13:451-469.
34. Gerber MA, Shapiro ED, Krause PJ, et al. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis. 1994;170:231-234.
35. Cable RG, Badon S, Trouern-Trend J, et al. Evidence for transmission of Babesia microti from Connecticut blood donors to recipients [abstract]. Transfusion. 2001;21(suppl):12S-13S.
36. Blue D, Graves V, McCarthy L, et al. Fatal transfusion-transmitted Babesia microti in the Midwest. Transfusion. 2009;49.
37. Houghton RL, Homer MJ, Reynolds LD, et al. Identification of babesia microti-specific immunodominant epitopes and development of a peptide EIA for detection of antibodies in serum. Transfusion. 2002;42:1488-1496.
38. Homer MJ, Lodes MJ, Reynolds LD, et al. Identification and characterization of putative secreted antigens from Babesia microti. J Clin Microbiol. 2003;41:723-729.
39. Grellier P, Benach J, Labaied M, et al. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion. 2008;48:1676-1684.
40. Grellier P, Santus R, Mouray E, et al. Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sanguinis. 1997;72:211-220.
41. Zavizion B, Pereira M, De Melo Jorge M, et al. Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry. Transfusion. 2004;44:731-738.
42. Gubernot DM, Lucey CT, Lee KC, Conley GB, Holness LG, Wise RP. Babesia infection through blood transfusion: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis. 2009;48:25-30.